These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8277160)

  • 1. Assessment of quality of life in the treatment of major depressive disorder with fluoxetine, 20 mg, in ambulatory patients aged over 60 years.
    Mesters P; Cosyns P; Dejaiffe G; Fanielle J; Gilles C; Godderis J; Grégoire J; de Leval N; Meire P; Mesotten F
    Int Clin Psychopharmacol; 1993; 8(4):337-40. PubMed ID: 8277160
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of fluoxetine and imipramine in the treatment of outpatients with major depressive disorder.
    Nielsen BM; Behnke K; Arup P; Christiansen PE; Geisler A; Ipsen E; Maach-Møller B; Ohrberg SC
    Acta Psychiatr Scand; 1993 Apr; 87(4):269-72. PubMed ID: 8488748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of fluoxetine versus placebo on functional health and well-being in late-life depression.
    Heiligenstein JH; Ware JE; Beusterien KM; Roback PJ; Andrejasich C; Tollefson GD
    Int Psychogeriatr; 1995; 7 Suppl():125-37. PubMed ID: 8580388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Depression in elderly physically ill in-patients: a 12-month prospective study.
    Evans ME
    Int Clin Psychopharmacol; 1993; 8(4):333-6. PubMed ID: 8277159
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind study of paroxetine compared with fluoxetine in geriatric patients with major depression.
    Schöne W; Ludwig M
    J Clin Psychopharmacol; 1993 Dec; 13(6 Suppl 2):34S-39S. PubMed ID: 8106654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the Hamilton Depression Rating Scale factors from a double-blind, placebo-controlled trial of fluoxetine in geriatric major depression.
    Tollefson GD; Holman SL
    Int Clin Psychopharmacol; 1993; 8(4):253-9. PubMed ID: 8277144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality disorder comorbidity with major depression and response to fluoxetine treatment.
    Fava M; Bouffides E; Pava JA; McCarthy MK; Steingard RJ; Rosenbaum JF
    Psychother Psychosom; 1994; 62(3-4):160-7. PubMed ID: 7846259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. The Venlafaxine French Inpatient Study Group.
    Clerc GE; Ruimy P; Verdeau-Pallès J
    Int Clin Psychopharmacol; 1994 Sep; 9(3):139-43. PubMed ID: 7814822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fluoxetine on psychomotor performance, cognitive function and sleep in depressed patients.
    Kerr JS; Fairweather DB; Hindmarch I
    Int Clin Psychopharmacol; 1993; 8(4):341-3. PubMed ID: 8277161
    [No Abstract]   [Full Text] [Related]  

  • 10. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine and desipramine in major depressive disorder.
    Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M
    J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Social adjustment does not predict depressive relapse during continuation fluoxetine therapy.
    Nierenberg AA; Grossbard SJ; Fava M; Rosenbaum JF
    J Affect Disord; 1995 May; 34(2):73-7. PubMed ID: 7665807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxetine in the elderly depressed patient: randomized comparison with fluoxetine of efficacy, cognitive and behavioural effects.
    Geretsegger C; Böhmer F; Ludwig M
    Int Clin Psychopharmacol; 1994; 9(1):25-9. PubMed ID: 8195578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative trial of fluoxetine and amitriptyline in patients with major depressive disorder.
    Feighner JP
    J Clin Psychiatry; 1985 Sep; 46(9):369-72. PubMed ID: 3897204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of low-dose fluoxetine in major depression and panic disorder.
    Louie AK; Lewis TB; Lannon RA
    J Clin Psychiatry; 1993 Nov; 54(11):435-8. PubMed ID: 8270588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind parallel study comparing fluoxetine with imipramine in the treatment of atypical depression.
    Stratta P; Bolino F; Cupillari M; Casacchia M
    Int Clin Psychopharmacol; 1991; 6(3):193-6. PubMed ID: 1806625
    [No Abstract]   [Full Text] [Related]  

  • 19. The Mini-Mental State Examination among adult outpatients with major depressive disorder.
    Alpert JE; Uebelacker LA; McLean NE; Abraham M; Rosenbaum JF; Fava M
    Psychother Psychosom; 1995; 63(3-4):207-11. PubMed ID: 7624468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients.
    Heiligenstein JH; Faries DE; Rush AJ; Andersen JS; Pande AC; Roffwarg HP; Dunner D; Gillin JC; James SP; Lahmeyer H
    Psychiatry Res; 1994 Jun; 52(3):327-39. PubMed ID: 7991725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.